These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas? Boto J; Guatta R; Fitsiori A; Hofmeister J; Meling TR; Vargas MI AJNR Am J Neuroradiol; 2021 Aug; 42(8):1421-1428. PubMed ID: 34117017 [TBL] [Abstract][Full Text] [Related]
3. A Deep Convolutional Neural Network With Performance Comparable to Radiologists for Differentiating Between Spinal Schwannoma and Meningioma. Maki S; Furuya T; Horikoshi T; Yokota H; Mori Y; Ota J; Kawasaki Y; Miyamoto T; Norimoto M; Okimatsu S; Shiga Y; Inage K; Orita S; Takahashi H; Suyari H; Uno T; Ohtori S Spine (Phila Pa 1976); 2020 May; 45(10):694-700. PubMed ID: 31809468 [TBL] [Abstract][Full Text] [Related]
4. Noncontrast T2-Weighted Magnetic Resonance Imaging Sequences for Long-Term Monitoring of Asymptomatic Convexity Meningiomas. He JQ; Iv M; Li G; Zhang M; Hayden Gephart M World Neurosurg; 2020 Mar; 135():e100-e105. PubMed ID: 31734418 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery. Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141 [TBL] [Abstract][Full Text] [Related]
6. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas. Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539 [TBL] [Abstract][Full Text] [Related]
7. 3D Fast Spin-Echo T1 Black-Blood Imaging for the Preoperative Detection of Venous Sinus Invasion by Meningioma : Comparison with Contrast-Enhanced MRV. Wang D; Lu Y; Yin B; Chen M; Geng D; Liu L; Wen J; Zhong P; Li Y Clin Neuroradiol; 2019 Mar; 29(1):65-73. PubMed ID: 29071386 [TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging (MRI) Differential Diagnosis of Meningiomas Using ANOVA. Liu J; Chen J; Zha Y; Huang Y; Zeng F Contrast Media Mol Imaging; 2021; 2021():4799116. PubMed ID: 34354552 [TBL] [Abstract][Full Text] [Related]
9. Automated Meningioma Segmentation in Multiparametric MRI : Comparable Effectiveness of a Deep Learning Model and Manual Segmentation. Laukamp KR; Pennig L; Thiele F; Reimer R; Görtz L; Shakirin G; Zopfs D; Timmer M; Perkuhn M; Borggrefe J Clin Neuroradiol; 2021 Jun; 31(2):357-366. PubMed ID: 32060575 [TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging and meningiomas of the posterior cerebral fossa. 31 cases]. Helie O; Soulie D; Sarrazin JL; Derosier C; Cordoliani YS; Cosnard G J Neuroradiol; 1995 Dec; 22(4):252-70. PubMed ID: 8636802 [TBL] [Abstract][Full Text] [Related]
11. Principal component analysis of texture features for grading of meningioma: not effective from the peritumoral area but effective from the tumor area. Mori N; Mugikura S; Endo T; Endo H; Oguma Y; Li L; Ito A; Watanabe M; Kanamori M; Tominaga T; Takase K Neuroradiology; 2023 Feb; 65(2):257-274. PubMed ID: 36044063 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of a Rim-Enhancing Pattern on the Contrast-Enhanced 3D-FLAIR Sequence and MRI Characteristics for Distinguishing Meningioma and Malignant Dural-Based Tumor. Panyaping T; Punpichet M; Tunlayadechanont P; Tritanon O AJNR Am J Neuroradiol; 2023 Mar; 44(3):247-253. PubMed ID: 36732030 [TBL] [Abstract][Full Text] [Related]
13. WHO grade I meningioma subtypes: MRI features and pathological analysis. Zhang T; Yu JM; Wang YQ; Yin DD; Fang LJ Life Sci; 2018 Nov; 213():50-56. PubMed ID: 30153449 [TBL] [Abstract][Full Text] [Related]
14. Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Lee M; Shin SJ; Oh YT; Jung DC; Cho NH; Choi YD; Park SY Eur Radiol; 2017 Sep; 27(9):3752-3758. PubMed ID: 28168374 [TBL] [Abstract][Full Text] [Related]
15. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging. Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748 [TBL] [Abstract][Full Text] [Related]
16. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI. Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255 [TBL] [Abstract][Full Text] [Related]
17. "Meningeal sign": a characteristic finding of meningiomas on contrast-enhanced MR images. Schörner W; Schubeus P; Henkes H; Lanksch W; Felix R Neuroradiology; 1990; 32(2):90-3. PubMed ID: 2204839 [TBL] [Abstract][Full Text] [Related]
18. High-field MRI using standard pulse sequences has moderate to substantial interobserver agreement and good accuracy for differentiation between intracranial extra-axial histiocytic sarcoma and meningioma in dogs. Mai W; Burke EE; Reetz JA; Hecht S; Paek M; Church ME; Werre SR; Mariani CL; Griffin JF; Glass EN Vet Radiol Ultrasound; 2022 Mar; 63(2):176-184. PubMed ID: 34881469 [TBL] [Abstract][Full Text] [Related]
19. Microcystic meningioma: importance of obvious hypointensity on T1-weighted magnetic resonance images. Chen CJ; Tseng YC; Hsu HL; Jung SM J Comput Assist Tomogr; 2008; 32(1):130-4. PubMed ID: 18303301 [TBL] [Abstract][Full Text] [Related]